I think the deal should and may get better. BO was all based on where this stock was in March. They offered a fair premium over march PPS while there was no clear path for FDA approval. Now that there is a clear path for FDA approval and most believe FDA approval will happen I would like to see the cash offer reflect our current PPS and defined regulatory path for FDA approval. IMO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.